Abstract Number: 1101 • 2017 ACR/ARHP Annual Meeting
Systematic Physician Assessment Beyond Inflammation in Routine Rheumatology Care Using Visual Analog Scale Scores for Inflammation, Damage, and Distress to Document Patient Status and Support Clinical Decisions: Analysis of Inter-Rater Reliability
Background/Purpose: A physician global estimate of patient status (DOCGL) on a 0-10 visual analog scales (VAS) is as effective as any rheumatoid arthritis (RA) Core…Abstract Number: 2992 • 2017 ACR/ARHP Annual Meeting
Curbing the Opioid Epidemic: Predictors of Opioid Use in Juvenile Fibromyalgia Syndrome
Background/Purpose: Despite the lack of evidence to support the use of opioids in the treatment of adult fibromyalgia syndrome, approximately 30% of patients receive an…Abstract Number: 1247 • 2017 ACR/ARHP Annual Meeting
Coexisting Fibromyalgia in Patients with Rheumatoid Arthritis Worsens Scores for Pain, Physical Function and Depression
Background/Purpose: Quality of life (QOL) measures as assessed by Patient Reported Outcome Measurement Information System (PROMIS) can contribute essential information about the status of or…Abstract Number: 1359 • 2017 ACR/ARHP Annual Meeting
M-DAS28, M-SDAI and M-CDAI Performance in a Cohort of RA Patients with and without Concomitant Fibromyalgia
Background/Purpose: Fibromyalgia has been reported in approximately 20% of Rheumatoid Arthritis (RA) patients. Several studies have shown that the presence of Fibromyalgia (FM) is associated…Abstract Number: 1653 • 2017 ACR/ARHP Annual Meeting
Factors Influencing on Health-Related Quality of Life in Female Systemic Lupus Erythematosus Patients with Fibromyalgia
Background/Purpose: Health-related quality of life (HRQoL) among systemic lupus erythematosus (SLE) patients is reduced, and fibromyalgia contribute to the decreased HRQoL. The objective of the…Abstract Number: 1868 • 2017 ACR/ARHP Annual Meeting
Association between Brain-Derived Neurotrophic Factor Gene Polymorphisms and Fibromyalgia in a Korean Population: A Multi-Center Study
Background/Purpose: Several lines of evidence suggest that brain-derived neurotrophic factor (BDNF) is involved in the pathophysiology of fibromyalgia (FM) and studies have found that FM…Abstract Number: 52 • 2016 ACR/ARHP Annual Meeting
Pregabalin Dose-Response for Sleep Quality and Pain Response in Fibromyalgia: A Post-Hoc Analysis of Three Randomized Trials
Background/Purpose: Pregabalin is often administered for treatment of fibromyalgia (FM) at daily doses lower than approved by the US Food and Drug Administration (starting dose…Abstract Number: 33 • 2016 ACR/ARHP Annual Meeting
Prevalence of Growth Hormone Deficiency in Fibromyalgia Patients
Background/Purpose: Low levels of Insulin-dependent growth factor 1 (IGF-1) have been described in Fibromyalgia (FM) patients, suggesting that they have adult growth hormone (GH) deficiency.…Abstract Number: 2200 • 2016 ACR/ARHP Annual Meeting
Association of Active Commuting and Physical Activity in Women with Fibromyalgia
Background/Purpose: Fibromyalgia symptomatology results in a low functional capacity1, limiting the daily activities and the quality of life of the patients2. Walking for commuting is…Abstract Number: 54 • 2016 ACR/ARHP Annual Meeting
Patients with Fibromyalgia in General Have Higher Self-Report Questionnaire Scores Than Patients with Rheumatoid Arthritis: Implications for Clinical Trials and Clinical Research
Background/Purpose: Patients with rheumatoid arthritis (RA) who are included in clinical trials generally are selected for measures indicating high disease activity, such as more than…Abstract Number: 42 • 2016 ACR/ARHP Annual Meeting
Small Fibre Neuropathy Biopsies (SFN) in Primary Fibromyalgia Revealed Predominant Association with Metabolic Syndrome (in addition to other known treatable causes of SFN) but No Clear Distinction Related to Biopsy Results
Background/Purpose: To assess patients with primary fibromyalgia (pFM) for small fibre neuropathy (SFN) and to correlate biopsy results between groups and with known causes of…Abstract Number: 2206 • 2016 ACR/ARHP Annual Meeting
Data on Treatment from Brazilian Fibromyalgia Patients Registry (EpiFibro)
Background/Purpose: The Brazilian registry on fibromyalgia syndrome (EpiFibro) included 810 patients who satisfied the American College of Rheumatology Classification Criteria for Fibromyalgia (ACR1990) at the…Abstract Number: 44 • 2016 ACR/ARHP Annual Meeting
Ambroxol for Fibromyalgia. One-Group Pretest-Posttest Open Label Clinical Observation
Background/Purpose: A consistent line of investigation proposes that fibromyalgia is a sympathetically maintained neuropathic pain syndrome. Moreover it has been suggested that dorsal root ganglia…Abstract Number: 2217 • 2016 ACR/ARHP Annual Meeting
Adherence to Drug Therapy in Patients with Fibromyalgia
Background/Purpose: As in other chronic diseases, adherence to the treatment regimen of patients with fibromyalgia (FM) is low (between 30 and 80%), depending on the…Abstract Number: 48 • 2016 ACR/ARHP Annual Meeting
Fibromyalgia Impact Is a Potential Mediator for the Associations of Self-Efficacy and Pain Catastrophizing with Physical Functioning in Persons with Fibromyalgia
Background/Purpose: Fibromyalgia (FM) is a chronic multidimensional disorder that causes physical and psychological impairment, incurring significant healthcare costs. Self-efficacy and pain catastrophizing have been shown…
- « Previous Page
- 1
- …
- 13
- 14
- 15
- 16
- 17
- …
- 25
- Next Page »
